A month has gone by since the last earnings report for Axsome Therapeutics (AXSM) . Shares have added about 4.8% in that time frame, underperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Axsome due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Axsome Q2 Loss Widens Y/Y, Revenues Beat Estimat ...